glp-1 and anxiety The risk of depression, anxiety, suicidal behavior in patients with obesity on glucagon like peptide-1 receptor agonist therapy A diabetes drug that quiets

Discovery and preclinical profile of Saxagliptin (BMS-477118): A highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes

But your body still needs fuel

Improvement in psoriasis after treatment with the glucagon-like peptide-1 receptor agonist liraglutide

The FDA also encourages healthcare providers and patients to report any adverse effects from GLP-1 and other medications

Consuming a high protein diet can help to maintain healthy muscles as bodyweight decreases

Keeping a symptom diary during the first 4 to 8 weeks helps separate these overlapping symptom sources